Ackermans & Van Haaren NV (LON:0GYM)
214.40
-1.00 (-0.46%)
At close: Jul 8, 2025
Ackermans & Van Haaren NV Revenue
In the year 2024, Ackermans & Van Haaren NV had annual revenue of 6.04B EUR with 15.74% growth. Ackermans & Van Haaren NV had revenue of 3.16B in the half year ending December 31, 2024, with 39.18% growth.
Revenue
6.04B EUR
Revenue Growth
+15.74%
P/S Ratio
1.20
Revenue / Employee
247.84K EUR
Employees
24,384
Market Cap
6.00B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.04B | 821.78M | 15.74% |
Dec 31, 2023 | 5.22B | 820.13M | 18.63% |
Dec 31, 2022 | 4.40B | 104.05M | 2.42% |
Dec 31, 2021 | 4.30B | 387.12M | 9.90% |
Dec 31, 2020 | 3.91B | -360.15M | -8.43% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |